These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

551 related articles for article (PubMed ID: 27319211)

  • 1. Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer.
    Srivastava A; Babu A; Filant J; Moxley KM; Ruskin R; Dhanasekaran D; Sood AK; McMeekin S; Ramesh R
    J Biomed Nanotechnol; 2016 Jun; 12(6):1159-73. PubMed ID: 27319211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes as drug carriers for clinical application.
    Di C; Zhang Q; Wang Y; Wang F; Chen Y; Gan L; Zhou R; Sun C; Li H; Zhang X; Yang H; Zhang H
    Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S564-S570. PubMed ID: 30431368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosome mediated communication within the tumor microenvironment.
    Milane L; Singh A; Mattheolabakis G; Suresh M; Amiji MM
    J Control Release; 2015 Dec; 219():278-294. PubMed ID: 26143224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comprehensive overview of exosomes as drug delivery vehicles - endogenous nanocarriers for targeted cancer therapy.
    Johnsen KB; Gudbergsson JM; Skov MN; Pilgaard L; Moos T; Duroux M
    Biochim Biophys Acta; 2014 Aug; 1846(1):75-87. PubMed ID: 24747178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-derived Exosomes as Promising Carriers for Drug Delivery and Targeted Therapy.
    Wang X; Zhang H; Yang H; Bai M; Ning T; Li S; Li J; Deng T; Ying G; Ba Y
    Curr Cancer Drug Targets; 2018; 18(4):347-354. PubMed ID: 28699500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics.
    Kim H; Kim EH; Kwak G; Chi SG; Kim SH; Yang Y
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current Perspectives of Exosomes as Therapeutic Targets and Drug Delivery Vehicles for Pancreatic Cancer.
    Srinivas L; S D; Kgk D; Malla RR
    Crit Rev Oncog; 2019; 24(2):179-190. PubMed ID: 31679212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From structures to functions: insights into exosomes as promising drug delivery vehicles.
    Ren J; He W; Zheng L; Duan H
    Biomater Sci; 2016 May; 4(6):910-21. PubMed ID: 26977477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering Exosomes for Cancer Therapy.
    Gilligan KE; Dwyer RM
    Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28538671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs.
    Chinnappan M; Srivastava A; Amreddy N; Razaq M; Pareek V; Ahmed R; Mehta M; Peterson JE; Munshi A; Ramesh R
    Cancer Lett; 2020 Aug; 486():18-28. PubMed ID: 32439419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications.
    Mondal J; Pillarisetti S; Junnuthula V; Saha M; Hwang SR; Park IK; Lee YK
    J Control Release; 2023 Jan; 353():1127-1149. PubMed ID: 36528193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-based nanocarriers as bio-inspired and versatile vehicles for drug delivery: recent advances and challenges.
    Zhang M; Zang X; Wang M; Li Z; Qiao M; Hu H; Chen D
    J Mater Chem B; 2019 Apr; 7(15):2421-2433. PubMed ID: 32255119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and regulation of exosome-based therapy products.
    Batrakova EV; Kim MS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Sep; 8(5):744-57. PubMed ID: 26888041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possibility of Exosome-Based Therapeutics and Challenges in Production of Exosomes Eligible for Therapeutic Application.
    Yamashita T; Takahashi Y; Takakura Y
    Biol Pharm Bull; 2018; 41(6):835-842. PubMed ID: 29863072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in the application of exosomes as therapeutic vectors in tumor-targeted therapy.
    Xie X; Wu H; Li M; Chen X; Xu X; Ni W; Lu C; Ni R; Bao B; Xiao M
    Cytotherapy; 2019 May; 21(5):509-524. PubMed ID: 30686589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes as nanocarriers for immunotherapy of cancer and inflammatory diseases.
    Tran TH; Mattheolabakis G; Aldawsari H; Amiji M
    Clin Immunol; 2015 Sep; 160(1):46-58. PubMed ID: 25842185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging Significance and Therapeutic Potential of Extracellular vesicles.
    Luo R; Liu M; Tan T; Yang Q; Wang Y; Men L; Zhao L; Zhang H; Wang S; Xie T; Tian Q
    Int J Biol Sci; 2021; 17(10):2476-2486. PubMed ID: 34326688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy.
    Zhan Q; Yi K; Qi H; Li S; Li X; Wang Q; Wang Y; Liu C; Qiu M; Yuan X; Zhao J; Hou X; Kang C
    Theranostics; 2020; 10(17):7889-7905. PubMed ID: 32685027
    [No Abstract]   [Full Text] [Related]  

  • 19. Exosomes: Therapy delivery tools and biomarkers of diseases.
    Barile L; Vassalli G
    Pharmacol Ther; 2017 Jun; 174():63-78. PubMed ID: 28202367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiological Role and Potential Therapeutic Exploitation of Exosomes in Ovarian Cancer.
    Shimizu A; Sawada K; Kimura T
    Cells; 2020 Mar; 9(4):. PubMed ID: 32230983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.